19.70

6.14% 1.14

After Hours: 19.75 0.05 +0.25%

Fulgent Genetics Inc (FLGT)

Overview News Price History Option Chain Financials Discussions Forecast

Fulgent Genetics Inc stock is traded at $19.70, with a volume of 369.00K. It is up +6.14% in the last 24 hours and up +11.55% over the past month. Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.

Previous Close:

$18.56

Open:

$18.56

24h Volume:

369.00K

Relative Volume:

0.81

Market Cap:

$625.31M

Revenue:

$290.71M

Net Income/Loss:

$-163.43M

P/E Ratio:

-3.5949

EPS:

-5.48

Net Cash Flow:

$11.70M

1W Performance:

-4.09%

1M Performance:

+11.55%

6M Performance:

+1.39%

1Y Performance:

-9.59%

1-Day Range:

$18.56

$19.72

1-Week Range:

$18.41

$20.43

52-Week Range:

$14.76

$25.11

Fulgent Genetics Inc Stock (FLGT) Company Profile

Name

Fulgent Genetics Inc

Sector

Healthcare (1153)

Industry

Diagnostics & Research (56)

Phone

626-350-0537

Address

4399 SANTA ANITA AVE, EL MONTE

Employee

1,313

Twitter

@FulgentGenetics

Next Earnings Date

2025-05-02

Latest SEC Filings

FLGT's Discussions on Twitter

Compare FLGT with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
FLGT Fulgent Genetics Inc	19.70	625.31M	290.71M	-163.43M	11.70M	-5.48
TMO Thermo Fisher Scientific Inc	403.13	159.89B	42.90B	6.52B	6.72B	17.05
DHR Danaher Corp	189.73	142.45B	23.82B	3.77B	4.90B	5.15
IDXX Idexx Laboratories Inc	491.70	37.95B	3.93B	894.97M	837.70M	10.82
A Agilent Technologies Inc	106.93	30.97B	6.53B	1.26B	1.31B	4.35
IQV Iqvia Holdings Inc	148.99	26.72B	15.50B	1.33B	2.16B	7.34

Fulgent Genetics Inc Stock (FLGT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-07-23	Initiated	UBS	Neutral
Dec-08-22	Downgrade	Piper Sandler	Overweight → Neutral
Nov-18-22	Initiated	Raymond James	Outperform
Aug-25-22	Initiated	Credit Suisse	Outperform
Feb-04-22	Resumed	Piper Sandler	Overweight
Aug-05-21	Resumed	Credit Suisse	Underperform
Jan-08-21	Downgrade	Credit Suisse	Neutral → Underperform
Nov-24-20	Downgrade	BTIG Research	Buy → Neutral
Aug-20-20	Initiated	Oppenheimer	Outperform
May-29-20	Initiated	BTIG Research	Buy
Nov-05-19	Upgrade	Piper Jaffray	Neutral → Overweight
Mar-01-18	Downgrade	Piper Jaffray	Overweight → Neutral
Nov-07-17	Downgrade	Raymond James	Outperform → Mkt Perform

View All

Fulgent Genetics Inc Stock (FLGT) Latest News

03:58 AM

Dimensional Fund Advisors LP Sells 60,579 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat

03:58 AM

02:35 AM

Fulgent Genetics (NASDAQ:FLGT) Shares Gap DownWhat's Next? - MarketBeat

02:35 AM

May 09, 2025

Caxton Associates LP Has $738,000 Holdings in Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat

May 09, 2025

Here's Why It's Unlikely That Fulgent Genetics, Inc.'s (NASDAQ:FLGT) CEO Will See A Pay Rise This Year - simplywall.st

May 09, 2025

Fulgent Genetics' (FLGT) "Outperform" Rating Reaffirmed at Raymond James - MarketBeat

May 09, 2025

May 08, 2025

Fulgent Genetics rises on earnings, revenue beat - MSN

May 08, 2025

Fulgent Genetics (NASDAQ:FLGT) Shares Gap Up After Better-Than-Expected Earnings - MarketBeat

May 08, 2025

Almitas Capital LLC Acquires New Shares in Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat

May 08, 2025

May 07, 2025

Fulgent Genetics (NASDAQ:FLGT) Updates FY 2025 Earnings Guidance - MarketBeat

May 07, 2025

May 06, 2025

Fulgent Genetics (FLGT) Price Target Boosted by Piper Sandler | - GuruFocus

May 06, 2025

Fulgent Genetics (FLGT) Sees Price Target Raised by Piper Sandler | FLGT Stock News - GuruFocus

May 06, 2025

Fulgent Genetics’ (FLGT) “Outperform” Rating Reaffirmed at Raymond James - Defense World

May 06, 2025

May 05, 2025

Fulgent Genetics (FLGT) Target Price Raised by Raymond James | F - GuruFocus

May 05, 2025

Fulgent Genetics (FLGT) Target Price Raised by Raymond James | FLGT Stock News - GuruFocus

May 05, 2025

Fulgent Genetics (FLGT) Sees Increased Price Target Following St - GuruFocus

May 05, 2025

Fulgent Genetics (NASDAQ:FLGT) Announces Quarterly Earnings Results - MarketBeat

May 05, 2025

Fulgent Genetics (FLGT) Sees Increased Price Target Following Strong Q1 Performance | FLGT Stock News - GuruFocus

May 05, 2025

Fulgent revenue up 16% to USD 73.5M in Q1 2025 - Medical Buyer

May 05, 2025

Is Fulgent Genetics (NASDAQ:FLGT) Using Too Much Debt? - simplywall.st

May 05, 2025

May 04, 2025

Park West Asset Management LLC Cuts Stock Position in Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat

May 04, 2025

Renaissance Technologies LLC Reduces Holdings in Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World

May 04, 2025

Nebula Research & Development LLC Takes Position in Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat

May 04, 2025

May 03, 2025

Fulgent Genetics, Inc. (NASDAQ:FLGT) Q1 2025 Earnings Call Transcript - Insider Monkey

May 03, 2025